Holdings A/S Novo - Feb 23, 2022 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc. (CMPI)

Role: 10%+ Owner
Signature: /s/ Barbara Fiorini Due, General Counsel, Novo Holdings A/S
Stock symbol: CMPI
Transactions as of: Feb 23, 2022
Transactions value $: -$23,067
Form type: 4
Date filed: 2/25/2022, 05:21 PM
Previous filing: Feb 9, 2022
Next filing: Jul 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMPI	Common Stock	Sale	-$5.28K	-1.82K	-0.08%	$2.90	2.17M	Feb 23, 2022	Direct
transaction	CMPI	Common Stock	Sale	-$17K	-5.99K	-0.28%	$2.83	2.16M	Feb 24, 2022	Direct	F1
transaction	CMPI	Common Stock	Sale	-$811	-300	-0.01%	$2.70	2.16M	Feb 25, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Holdings A/S Novo is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.79 to $2.91. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price noted in this footnote.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.79 to $2.91. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price noted in this footnote.